Literature DB >> 6235889

Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.

J S Mann, P H Howarth, S T Holgate.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235889      PMCID: PMC1442589          DOI: 10.1136/bmj.289.6443.469

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  The effects of ultrasonically-produced aerosols on airway resistance in man.

Authors:  F W Cheney; J Butler
Journal:  Anesthesiology       Date:  1968 Nov-Dec       Impact factor: 7.892

2.  Bronchoconstriction in response to ipratropium bromide.

Authors:  P H Howarth
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-04

3.  Bronchoconstriction in response to ipratropium bromide.

Authors:  K R Patel; W M Tullett
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

4.  Adverse reaction to ipratropium bromide.

Authors:  C K Connolly
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

5.  Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.

Authors:  R E Schoeffel; S D Anderson; R E Altounyan
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-14
  5 in total
  15 in total

Review 1.  HRCT imaging of airway responsiveness: effects of anesthetics.

Authors:  R H Brown
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 2.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

3.  Nebulisers for asthma.

Authors:  M J Ward
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  BMJ       Date:  1989-12-09

5.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 6.  Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update.

Authors:  Maria Gabriella Matera; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

7.  Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion.

Authors:  P Rafferty; R Beasley; P H Howarth; J S Mann; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

Review 8.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 9.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.

Authors:  C R Beasley; P Rafferty; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.